Okamoto M - Search Results

1

Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less.

Okamoto M, Fujimoto K, Chikasue T, Yanagihara T, Tabata K, Zaizen Y, Tominaga M, Sumi A, Takeoka H, Matsuo N, Nouno T, Kawaguchi A, Hoshino T. Okamoto M, et al. Respir Investig. 2024 Dec 16;63(1):109-117. doi: 10.1016/j.resinv.2024.12.005. Online ahead of print. Respir Investig. 2024. PMID: 39689588

2

Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.

Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T. Yoshida N, et al. Among authors: okamoto m. Respir Investig. 2017 Jan;55(1):24-32. doi: 10.1016/j.resinv.2016.08.007. Epub 2016 Sep 30. Respir Investig. 2017. PMID: 28012490

3

Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositis.

Sakamoto S, Okamoto M, Kaieda S, Fujimoto K, Nagata S, Tominaga M, Nakamura M, Zaizen Y, Nouno T, Koga T, Kawayama T, Kuwana M, Ida H, Hoshino T. Sakamoto S, et al. Among authors: okamoto m. Respir Investig. 2018 Nov;56(6):464-472. doi: 10.1016/j.resinv.2018.07.007. Epub 2018 Aug 24. Respir Investig. 2018. PMID: 30150008

4

Obesity may be a risk factor for transbronchial lung cryobiopsy-related adverse events in Japanese patients with interstitial lung disease.

Zaizen Y, Umemoto S, Matama G, Mitsui Y, Horii T, Yano R, Tsuneyoshi S, Sasaki J, Ishii H, Okamoto M, Tominaga M, Hoshino T. Zaizen Y, et al. Among authors: okamoto m. Respir Investig. 2024 Jan;62(1):102-106. doi: 10.1016/j.resinv.2023.11.002. Epub 2023 Dec 8. Respir Investig. 2024. PMID: 38070359

5

Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis.

Tajiri M, Okamoto M, Fujimoto K, Johkoh T, Ono J, Tominaga M, Azuma K, Kawayama T, Ohta S, Izuhara K, Hoshino T. Tajiri M, et al. Among authors: okamoto m. Respir Investig. 2015 Mar;53(2):73-81. doi: 10.1016/j.resinv.2014.12.003. Epub 2015 Jan 19. Respir Investig. 2015. PMID: 25745852

6

A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.

Okamoto M, Fujimoto K, Sadohara J, Furuya K, Kaieda S, Miyamura T, Suematsu E, Kitasato Y, Kawayama T, Ida H, Ichiki M, Hoshino T. Okamoto M, et al. Respir Investig. 2016 Nov;54(6):445-453. doi: 10.1016/j.resinv.2016.05.004. Epub 2016 Jun 30. Respir Investig. 2016. PMID: 27886856

7

Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis.

Tominaga M, Okamoto M, Kawayama T, Matsuoka M, Kaieda S, Sakazaki Y, Kinoshita T, Mori D, Inoue A, Hoshino T. Tominaga M, et al. Among authors: okamoto m. Respir Investig. 2017 Sep;55(5):293-299. doi: 10.1016/j.resinv.2017.06.001. Epub 2017 Aug 12. Respir Investig. 2017. PMID: 28942884

8

A retrospective study of the tolerability of nintedanib for severe idiopathic pulmonary fibrosis in the real world.

Nakamura M, Okamoto M, Fujimoto K, Ebata T, Tominaga M, Nouno T, Zaizen Y, Kaieda S, Tsuda T, Kawayama T, Hoshino T. Nakamura M, et al. Among authors: okamoto m. Ann Transl Med. 2019 Jun;7(12):262. doi: 10.21037/atm.2019.05.33. Ann Transl Med. 2019. PMID: 31355229 Free PMC article.

9

A Case of Autoimmune Pulmonary Alveolar Proteinosis with Pulmonary Fibrosis and Asbestosis-Like Features.

Nakamura M, Okamoto M, Fujimoto K, Shimizu S, Tominaga M, Tsuneyoshi S, Zaizen Y, Nouno T, Sakamoto S, Kawayama T, Hoshino T. Nakamura M, et al. Among authors: okamoto m. Kurume Med J. 2020 Jul 1;66(1):59-63. doi: 10.2739/kurumemedj.MS661005. Epub 2020 Apr 24. Kurume Med J. 2020. PMID: 32336733 Free article.

10

Early Intervention of Pulmonary Rehabilitation for Fibrotic Interstitial Lung Disease Is a Favorable Factor for Short-Term Improvement in Health-Related Quality of Life.

Matsuo S, Okamoto M, Ikeuchi T, Zaizen Y, Inomoto A, Haraguchi R, Mori S, Sasaki R, Nouno T, Tanaka T, Hoshino T, Tsuda T. Matsuo S, et al. Among authors: okamoto m. J Clin Med. 2021 Jul 16;10(14):3153. doi: 10.3390/jcm10143153. J Clin Med. 2021. PMID: 34300319 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,809 results

Search Page

Filters